Switch to: References

Citations of:

Ethics and regulation of clinical research

Baltimore: Urban & Schwarzenberg (1981)

Add citations

You must login to add citations.
  1. Stakeholder engagement in clinical research: an ethical analysis.Solveig Lena Hansen, Tim Holetzek, Clemens Heyder & Claudia Wiesemann - 2018 - Ethik in der Medizin 30 (4):289-305.
    ZusammenfassungDer vorliegende Beitrag untersucht, wie angesichts eines Interessenpluralismus ethische Diskurse über innovative und hochriskante Forschungsvorhaben angemessen geführt werden können. Dazu rekonstruieren wir erstens den Begriff des Stakeholders im Kontext seiner Entstehung in der Unternehmensethik und Anwendung in der Medizinethik und legen dessen implizite normative Prämissen frei. Wir entwickeln zweitens eine Klassifizierung von Stakeholdern und illustrieren diese am Beispiel der klinischen Forschung. Besonderes Augenmerk wird dabei auf das Kriterium der Betroffenheit gelegt. Drittens werden für unterschiedliche Formen der Betroffenheit von Stakeholdern angemessene (...)
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • An Ethical Justification for Research with Children.Ariella Binik - unknown
    This thesis is a contribution to the ethical justification for clinical research with children. A research subject’s participation in a trial is usually justified, in part, by informed consent. Informed consent helps to uphold the moral principle of respect for persons. But children’s limited ability to make informed choices gives rise to a problem. It is unclear what, if anything, justifies their participation in research. Some research ethicists propose to resolve this problem by appealing to social utility, proxy consent, arguments (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Institutional review boards: A flawed system of risk management.Simon N. Whitney - 2016 - Research Ethics 12 (4):182-200.
    Institutional Review Boards and their federal overseers protect human subjects, but this vital work is often dysfunctional despite their conscientious efforts. A cardinal, but unrecognized, explanation is that IRBs are performing a specific function – the management of risk – using a flawed theoretical and practical approach. At the time of the IRB system’s creation, risk management theory emphasized the suppression of risk. Since then, scholars of governance, studying the experience of business and government, have learned that we must distinguish (...)
    Download  
     
    Export citation  
     
    Bookmark   5 citations  
  • Ensayos clínicos e interés general.David Teira Serrano - 2008 - Arbor 184 (730):207-216.
    Este artículo estudia la justificación normativa de la adopción de los ensayos clínicos aleatorizados por parte de las autoridades sanitarias británicas como estándar metodológico en 1946. A partir de un análisis de los distintos intereses de los participantes en el proceso (pacientes, médicos, farmacéuticas y el propio Estado) argumentamos que la aleatorización se adoptó como mecanismo de asignación imparcial de tratamientos, aunque sus propiedades estadísticas no fueran bien comprendidas. Tal justificación permanece aún vigente.
    Download  
     
    Export citation  
     
    Bookmark  
  • Chimeras, Moral Status, and Public Policy: Implications of the Abortion Debate for Public Policy on Human/Nonhuman Chimera Research.Robert Streiffer - 2010 - Journal of Law, Medicine and Ethics 38 (2):238-250.
    Moral status is the moral value that something has in its own right, independently of the interests or concerns of others. Research using human embryonic stem cells implicates issues about moral status because the current method of extracting hESCs involves the destruction of a human embryo, the moral status of which is contested. Moral status issues can also arise, however, when hESCs are transplanted into embryonic or fetal animals, thereby creating human/ nonhuman stem cell chimeras. In particular, one concern about (...)
    Download  
     
    Export citation  
     
    Bookmark   13 citations  
  • Genetic Research as Therapy: Implications of "Gene Therapy" for Informed Consent.Larry R. Churchill, Myra L. Collins, Nancy M. R. King, Stephen G. Pemberton & Keith A. Wailoo - 1998 - Journal of Law, Medicine and Ethics 26 (1):38-47.
    In March 1996, the General Accounting Office (GAO) issued the reportScientific Research: Continued Vigilance Critical to Protecting Human Subjects.It stated that “an inherent conflict of interest exists when physician-researchers include their patients in research protocols. If the physicians do not clearly distinguish between research and treatment in their attempt to inform subjects, the possible benefits of a study can be overemphasized and the risks minimized.” The report also acknowledged that “the line between research and treatment is not always cleartoclinicians. Controversy (...)
    Download  
     
    Export citation  
     
    Bookmark   10 citations  
  • To research (or not) that is the question: ethical issues in research when medical care is disrupted by political action: a case study from Eldoret, Kenya.Darlene R. House, Irene Marete & Eric M. Meslin - 2016 - Journal of Medical Ethics 42 (1):61-65.
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Re-visioning Clinical Research: Gender and the Ethics of Experimental Design.Sue V. Rosser - 1989 - Hypatia 4 (2):125-139.
    Since modern medicine is based substantially in clinical medical research, the flaws and ethical problems that arise in this research as it is conceived and practiced in the United States are likely to be reflected to some extent in current medicine and its practice. This paper explores some of the ways in which clinical research has suffered from an androcentric focus in its choice and definition of problems studied, approaches and methods used in design and interpretation of experiments, and theories (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Compliance Disengagement in Research: Development and Validation of a New Measure.James M. DuBois, John T. Chibnall & John Gibbs - 2016 - Science and Engineering Ethics 22 (4):965-988.
    In the world of research, compliance with research regulations is not the same as ethics, but it is closely related. One could say that compliance is how most societies with advanced research programs operationalize many ethical obligations. This paper reports on the development of the How I Think about Research questionnaire, which is an adaptation of the How I Think questionnaire that examines the use of cognitive distortions to justify antisocial behaviors. Such an adaptation was justified based on a review (...)
    Download  
     
    Export citation  
     
    Bookmark   4 citations  
  • Respect for Human Vulnerability: The Emergence of a New Principle in Bioethics.Henk ten Have - 2015 - Journal of Bioethical Inquiry 12 (3):395-408.
    Vulnerability has become a popular though controversial topic in bioethics, notably since 2000. As a result, a common body of knowledge has emerged distinguishing between different types of vulnerability, criticizing the categorization of populations as vulnerable, and questioning the practical implications. It is argued that two perspectives on vulnerability, i.e., the philosophical and political, pose challenges to contemporary bioethics discourse: they re-examine the significance of human agency, the primacy of the individual person, and the negativity of vulnerability. As a phenomenon (...)
    Download  
     
    Export citation  
     
    Bookmark   17 citations  
  • Can informed consent to research be adapted to risk?Danielle Bromwich & Annette Rid - 2015 - Journal of Medical Ethics 41 (7):521-528.
    The current ethical and regulatory framework for research is often charged with burdening investigators and impeding socially valuable research. To address these concerns, a growing number of research ethicists argue that informed consent should be adapted to the risks of research participation. This would require less rigorous consent standards in low-risk research than in high-risk research. However, the current discussion is restricted to cases of research in which the risks of research participation are outweighed by the potential clinical benefits for (...)
    Download  
     
    Export citation  
     
    Bookmark   5 citations  
  • Understanding, interests and informed consent: a reply to Sreenivasan.Danielle Bromwich - 2015 - Journal of Medical Ethics 41 (4):327-331.
    It is widely agreed that the view of informed consent found in the regulations and guidelines struggles to keep pace with the ever-advancing enterprise of human subjects research. Over the last 10 years, there have been serious attempts to rethink informed consent so that it conforms to our considered judgments about cases where we are confident valid consent has been given. These arguments are influenced by an argument from Gopal Sreenivasan, which apparently shows that a potential participant9s consent to research (...)
    Download  
     
    Export citation  
     
    Bookmark   8 citations  
  • History of Clinical Research and Ethics.Shamima Parvin Lasker - 2013 - Bangladesh Journal of Bioethics 4 (1):20-29.
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Informed consent and the use of placebo in poland: Ethical and legal aspects. [REVIEW]Prof Piotr Zaborowski & Adam Górski - 2004 - Science and Engineering Ethics 10 (1):167-178.
    The concept of informed consent was one of the most fruitful ideas that deeply changed the relationships between physicians and their patients from paternalism to respect for the personal autonomy of subjects needing professional medical care. The great progress in medicine, also involving the pharmaceutical industry, has created an increasing need to perform different clinical and experimental trials. The evolution of clinical research in the last decades has influenced strongly the design of these studies. One of the most important changes (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Forgoing Debriefing in Deceptive Research: Is It Ever Ethical?Roseanna Sommers & Franklin G. Miller - 2013 - Ethics and Behavior 23 (2):98-116.
    The use of deception in research is generally permitted so long as participants are debriefed at the conclusion of their participation. Several authoritative research ethics guidelines allow investigators to omit debriefing under certain circumstances, however. Here we examine various justifications for forgoing debriefing in deceptive research, including concerns about subject pool contamination, the risk that revealing the deception will be harmful or distressing to participants, and issues of practicability. We conclude that, contrary to current practice, omitting debriefing is ethically acceptable (...)
    Download  
     
    Export citation  
     
    Bookmark   7 citations  
  • Protecting Research Subjects from Prohibited Multi-Participation in Clinical Trials.Hans-Peter Graf - 2011 - Research Ethics 7 (4):136-147.
    The protection of human research subjects in clinical studies is regulated by international guidelines and national laws. Research Ethics Committees play an important role here, as they review the documentation for clinical studies under consideration of ethical aspects. This documentation includes an exclusion or wash-out period which designates when study subjects may not have participated in another study or be allowed to take part in a future one within a specified time period. However not all research subjects comply with their (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Manipulation of information in medical research: Can it be morally justified?Sapfo Lignou & Sarah Jl Edwards - 2012 - Research Ethics 8 (1):9-23.
    The aim of this article is to examine whether informational manipulation, used intentionally by the researcher to increase recruitment in the research study, can be morally acceptable. We argue that this question is better answered by following a non-normative account, according to which the ethical justifiability of informational manipulation should not be relevant to its definition. The most appropriate criterion by which informational manipulation should be considered as morally acceptable or not is the researcher’s special moral duties towards their subjects. (...)
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • The historical foundations of the research-practice distinction in bioethics.Tom L. Beauchamp & Yashar Saghai - 2012 - Heoretical Medicine and Bioethics 33 (1):45-56.
    The distinction between clinical research and clinical practice directs how we partition medicine and biomedical science. Reasons for a sharp distinction date historically to the work of the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, especially to its analysis of the “boundaries” between research and practice in the Belmont Report (1978). Belmont presents a segregation model of the research-practice distinction, according to which research and practice form conceptually exclusive sets of activities and interventions. This (...)
    Download  
     
    Export citation  
     
    Bookmark   16 citations  
  • Exploitation and biomedical research in the developing world.David McLauchlan - unknown
    The exploitation of participants is a significant problem in biomedical research, especially in the developing world. However, there is a gap between this problem and the theoretical literature on exploitation. This thesis will attempt to bridge it, considering Wertheimer and Sample’s theories. Whereas Wertheimer holds that exploitation is merely an unjust distribution of the “social surplus” arising from a transaction, Sample, whose approach this thesis endorses, construes exploitation as a lack of respect for a person’s true value. This thesis will (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Are the Votes of Ethics Committees in Germany for the Protection of Clinical Study Trial Subjects “Sovereign Acts?”.Hans-Peter Graf - 2013 - Science and Engineering Ethics 19 (2):341-354.
    A sudden paradigm shift has resulted in governmental measures that greatly impact the scope in which the ethics committees in Germany can perform their task of providing expert opinions for clinical research. The so-called “revaluation” of the Medical Device Law Deutsches Medizinproduktegesetz—MPG) is, in our opinion, not based on sound political and professional judgment. In accordance with the changed regulations, ethics committees are now seen as being sub-organs of the state medical associations or the medical faculties and are therefore official (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • A framework for risk-benefit evaluations in biomedical research.Annette Rid & David Wendler - 2011 - Kennedy Institute of Ethics Journal 21 (2):141-179.
    One of the key ethical requirements for biomedical research is that it have an acceptable risk-benefit profile (Emanuel, Wendler, and Grady 2000). The International Conference of Harmonization guidelines mandate that clinical trials should be initiated and continued only if “the anticipated benefits justify the risks” (1996). Guidelines from the Council for International Organizations of Medical Sciences state that biomedical research is acceptable only if the “potential benefits and risks are reasonably balanced” (2002). U.S. federal regulations require that the “risks to (...)
    Download  
     
    Export citation  
     
    Bookmark   29 citations  
  • Is There a Duty to Share? Ethics of Sharing Research Data in the Context of Public Health Emergencies.P. Langat, D. Pisartchik, D. Silva, C. Bernard, K. Olsen, M. Smith, S. Sahni & R. Upshur - 2011 - Public Health Ethics 4 (1):4-11.
    Making research data readily accessible during a public health emergency can have profound effects on our response capabilities. The moral milieu of this data sharing has not yet been adequately explored. This article explores the foundation and nature of a duty, if any, that researchers have to share data, specifically in the context of public health emergencies. There are three notable reasons that stand in opposition to a duty to share one’s data, relating to: (i) data property and ownership, (ii) (...)
    Download  
     
    Export citation  
     
    Bookmark   12 citations  
  • Research Ethics and Misguided Moral Intuition.Franklin G. Miller - 2004 - Journal of Law, Medicine and Ethics 32 (1):111-116.
    The term therapeutic misconception was coined by Paul Appelbaum and his colleagues to describe the tendency of patients enrolled in clinical trials to confuse research participation with the personal clinical attention characteristic of medical care. It has not been recognized that an analogous therapeutic misconception pervades ethical thinking about clinical research with patient-subjects. Investigators and bioethicists often judge the ethics of clinical research based on ethical standards appropriate to the physician-patient relationship in therapeutic medicine. This ethical approach to clinical research (...)
    Download  
     
    Export citation  
     
    Bookmark   11 citations  
  • The evaluation of the risks and benefits of phase II cancer clinical trials by institutional review board (IRB) members: a case study.H. E. M. van Luijn - 2006 - Journal of Medical Ethics 32 (3):170-176.
    Objectives: There are indications that institutional review board members do not find it easy to assess the risks and benefits in medical experiments, although this is their principal duty. This study examined how IRB members assessed the risk/benefit ratio of a specific phase II breast cancer clinical trial.Participants and methods: The trial was evaluated by means of a questionnaire administered to 43 members of IRBs at six academic hospitals and specialised cancer centres in the Netherlands. The questionnaire addressed: identification and (...)
    Download  
     
    Export citation  
     
    Bookmark   7 citations  
  • Eliminating the daily life risks standard from the definition of minimal risk.D. B. Resnik - 2005 - Journal of Medical Ethics 31 (1):35-38.
    The phrase “minimal risk,” as defined in the United States’ federal research regulations, is ambiguous and poorly defined. This article argues that most of the ambiguity that one finds in the phrase stems from the “daily life risks” standard in the definition of minimal risk. In this article, the author argues that the daily life risks standard should be dropped and that “minimal risk” should be defined as simply “the probability and magnitude of the harm or discomfort anticipated in research (...)
    Download  
     
    Export citation  
     
    Bookmark   23 citations  
  • Innovative therapies, suspended trials, and the economics of clinical research: Facilitated communication and biomedical cases.James R. Wible & Susan Dietrich - 2002 - Philosophy of the Social Sciences 32 (3):275-309.
    University of North Carolina at Greensboro Most approaches to the philosophy of the natural and social sciences are basedon completed scientific investigations. However, there are many importantcases in science in which testing is incomplete. These cases are termed suspendedtrials and are particularly significant in biomedical and allied health fields. Initially,the authors' interest in suspended trials was piqued by a controversialmethod for assisting autistic children known as facilitated communication. Thisarticle examines facilitated communication and other examples of suspendedtrials from the perspective of (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Informed consent and the use of placebo in Poland: Ethical and legal aspects.Piotr Zaborowski & Adam Górski - 2004 - Science and Engineering Ethics 10 (1):167-178.
    The concept of informed consent was one of the most fruitful ideas that deeply changed the relationships between physicians and their patients from paternalism to respect for the personal autonomy of subjects needing professional medical care. The great progress in medicine, also involving the pharmaceutical industry, has created an increasing need to perform different clinical and experimental trials. The evolution of clinical research in the last decades has influenced strongly the design of these studies. One of the most important changes (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Investigators' affirmation of ethical, safeguard, and scientific commitments in human research.Laura Weiss Roberts & Timothy L. McAuliffe - 2006 - Ethics and Behavior 16 (2):135 – 150.
    Little is known about how researchers view ethically salient aspects of human studies. As part of a National Institutes of Mental Health-funded study, the authors performed a confidential written survey to assess the attitudes, views, and experiences of researchers with institutional review board approved protocols at the University of New Mexico. A total of 363 researchers (57% response rate) participated. Investigators overall held favorable views of general ethical aspects of research and ethics-based safeguards, and they identified a positive role of (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Nurses' participation in the institutional bioethical debate in the netherlands.Brigitte Prevos & Arie van der Arend - 1994 - HEC Forum 6 (4):235-256.
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Vulnerability: Reflection on its ethical implications for the protection of participants in SAMHSA programs.Thomas F. Mcgovern - 1998 - Ethics and Behavior 8 (4):293 – 304.
    The vulnerability of participants in Substance Abuse and Mental Health Services Administration (SAMHSA) programs is a consequence of the illnesses that they are experiencing; ethical guarantees must be in place that ensure the dignity of the persons involved in such programs. Dignity is more than an individual concern; it has individual, institutional, and societal dimensions. An ethical framework is proposed that involves the interrelated vulnerabilities and needs of individuals and communities and our societal response to them. Among the issues given (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • Ethical review of innovative treatment.Donald Evans - 2002 - HEC Forum 14 (1):53-63.
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Children's capacity to agree to psychological research: Knowledge of risks and benefits and voluntariness.Rona Abramovitch, Jonathan L. Freedman, Kate Henry & Michelle Van Brunschot - 1995 - Ethics and Behavior 5 (1):25 – 48.
    A series of studies investigated the capacity of children between the ages of 7 and 12 to give free and informed consent to participation in psychological research. Children were reasonably accurate in describing the purpose of studies, but many did not understand the possible benefits or especially the possible risks of participating. In several studies children's consent was not affected by the knowledge that their parents had given their permission or by the parents saying that they would not be upset (...)
    Download  
     
    Export citation  
     
    Bookmark   12 citations  
  • Advance research directives: avoiding double standards.Bert Heinrichs - 2021 - BMC Medical Ethics 22 (1):1-8.
    BackgroundAdvance research directives (ARD) have been suggested as a means by which to facilitate research with incapacitated subjects, in particular in the context of dementia research. However, established disclosure requirements for study participation raise an ethical problem for the application of ARDs: While regular consent procedures call for detailed information on a specific study (“token disclosure”), ARDs can typically only include generic information (“type disclosure”). The introduction of ARDs could thus establish a double standard in the sense that within the (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • The Construction of Lay Expertise: AIDS Activism and the Forging of Credibility in the Reform of Clinical Trials.Steven Epstein - 1995 - Science, Technology and Human Values 20 (4):408-437.
    In an unusual instance of lay participation in biomedical research, U.S. AIDS treatment activists have constituted themselves as credible participants in the process of knowledge construction, thereby bringing about changes in the epistemic practices of biomedical research. This article examines the mechanisms or tactics by which these lay activists have constructed their credibility in the eyes of AIDS researchers and government officials. It considers the inwlications of such interventions for the conduct of medical research; examines some of the ironies, tensions, (...)
    Download  
     
    Export citation  
     
    Bookmark   77 citations  
  • Overseeing Research Practice: The Case of Data Editing.Erin Leahey - 2008 - Science, Technology, and Human Values 33 (5):605-630.
    This article examines whether and how a particular research practice is overseen and supervised, and by whom. This investigation fills notable gaps in the literature on science, including a lack of emphasis on larger sociopolitical structures, a neglect of regulation, and indifference toward ethics. The author focuses on the oversight of a particular research practice; data editing; which embodies qualities that are intriguing to sociologists of science: invisibility, uncertainty, heterogeneity, and reliance on tacit knowledge. These characteristics pose unique challenges to (...)
    Download  
     
    Export citation  
     
    Bookmark   8 citations  
  • Duties When an Anonymous Student Health Survey Finds a Hot Spot of Suicidality.Arnold H. Levinson, M. Franci Crepeau-Hobson, Marilyn E. Coors, Jacqueline J. Glover, Daniel S. Goldberg & Matthew K. Wynia - 2020 - American Journal of Bioethics 20 (10):50-60.
    Public health agencies regularly survey randomly selected anonymous students to track drug use, sexual activities, and other risk behaviors. Students are unidentifiable, but a recent project that i...
    Download  
     
    Export citation  
     
    Bookmark   9 citations  
  • The Regulation of COVID-19 “Challenge” Studies.Jerry Menikoff - 2020 - American Journal of Bioethics 20 (7):80-82.
    Volume 20, Issue 7, July 2020, Page 80-82.
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • Die Entwicklung des Konzepts der Einwilligung nach Aufklärung in der psychiatrischen Forschung.Hanfried Helmchen - 2019 - Ethik in der Medizin 31 (3):207-220.
    ZusammenfassungDas juristische Konzept der Einwilligung nach Aufklärung ist im Respekt vor dem Selbstbestimmungsrecht begründet. Es entwickelte sich seit Ende des 19. Jahrhunderts, gewann mit der rapiden Ausweitung der klinischen Forschung seit Mitte des 20. Jahrhunderts mittels der Deklaration von Helsinki und seit 1972 in den USA als Konzept des informed consent erhebliche Bedeutung in der klinischen Forschung, nachfolgend auch in der klinischen Praxis. Die psychiatrische Forschung stieß bald auf das grundlegende ethische Problem, dass psychische Krankheiten die Einwilligungsfähigkeit und damit die (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Adolescent and Parent Perspectives on Ethical Issues in Youth Drug Use and Suicide Survey Research.Celia B. Fisher - 2003 - Ethics and Behavior 13 (4):303-332.
    The contributions of adolescent and parent perspectives to ethical planning of survey research on youth drug use and suicide behaviors are highlighted through an empirical examination of 322 7th-12th graders' and 160 parents' opinions on questions related to 4 ethical dimensions of survey research practice: evaluating research risks and benefits, establishing guardian permission requirements, developing confidentiality and disclosure policies, and using cash incentives for recruitment. Generational and ethnic variation in response to questionnaire items developed from discussions within adolescent and parent (...)
    Download  
     
    Export citation  
     
    Bookmark   7 citations  
  • Setting risk thresholds in biomedical research: lessons from the debate about minimal risk.Annette Rid - 2014 - Monash Bioethics Review 32 (1-2):63-85.
    One of the fundamental ethical concerns about biomedical research is that it frequently exposes participants to risks for the benefit of others. To protect participants’ rights and interests in this context, research regulations and guidelines set out a mix of substantive and procedural requirements for research involving humans. Risk thresholds play an important role in formulating both types of requirements. First, risk thresholds serve to set upper risk limits in certain types of research. Second, risk thresholds serve to demarcate risk (...)
    Download  
     
    Export citation  
     
    Bookmark   6 citations  
  • DNA databanks and consent: A suggested policy option involving an authorization model.Daar Abdallah, E. G. Upshur Ross & Caulfield Timothy - 2003 - BMC Medical Ethics 4 (1):1.
    Background Genetic databases are becoming increasingly common as a means of determining the relationship between lifestyle, environmental exposures and genetic diseases. These databases rely on large numbers of research subjects contributing their genetic material to successfully explore the genetic basis of disease. However, as all possible research questions that can be posed of the data are unknown, an unresolved ethical issue is the status of informed consent for future research uses of genetic material. Discussion In this paper, we discuss the (...)
    Download  
     
    Export citation  
     
    Bookmark   9 citations  
  • Children with AIDS in the public schools: The ethical issues.Dena S. Davis - 1987 - Journal of Medical Humanities and Bioethics 8 (2):101-109.
    The question of whether to allow children with AIDS to attend public school generates explosive emotions and has wide-reaching consequences. This paper focuses on the perspective of parents of well children who may be asked to attend school with children who have AIDS. These parents are poised at the heart of the dilemma: they are the ethical “bottom line,” and an argument that fails to satisfy them ought not to satisfy anyone.
    Download  
     
    Export citation  
     
    Bookmark  
  • Unequal treatment of human research subjects.David B. Resnik - 2015 - Medicine, Health Care and Philosophy 18 (1):23-32.
    Unequal treatment of human research subjects is a significant ethical concern, because justice in research involving human subjects requires equal protection of rights and equal protection from harm and exploitation. Disputes sometimes arise concerning the issue of unequal treatment of research subjects. Allegedly unequal treatment occurs when subjects are treated differently and there is a genuine dispute concerning the appropriateness of equal treatment. Patently unequal treatment occurs when subjects are treated differently and there is not a genuine dispute about the (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Human Subjects Protections in Biomedical Enhancement Research: Assessing Risk and Benefit and Obtaining Informed Consent.Maxwell J. Mehlman & Jessica W. Berg - 2008 - Journal of Law, Medicine and Ethics 36 (3):546-559.
    There are two critical steps in determining whether a medical experiment involving human subjects can be conducted in an ethical manner: assessing risks and potential benefits and obtaining potential subjects’ informed consent. Although an extensive literature on both of these aspects exists, virtually nothing has been written about human experimentation for which the objective is not to prevent, cure, or mitigate a disease or condition, but to enhance human capabilities. One exception is a 2004 article by Rebecca Dresser on preimplantation (...)
    Download  
     
    Export citation  
     
    Bookmark   8 citations  
  • Ending Concerns about Undue Inducement.Ezekiel J. Emanuel - 2004 - Journal of Law, Medicine and Ethics 32 (1):100-105.
    For decades, worries about undue inducement have Pervaded clinical research, and are especially common when research is accompanied by payment or conducted in developing countries. Few ethical judgments carry as much moral opprobrium or are thought to undermine the ethical soundness of a clinical trial as thoroughly as undue inducement. Indeed, the admonition to prevent undue inducement is one of the few explicit instructions in the Common Rules requirements for informed consent.Despite their long history and pervasiveness, charges of undue inducement (...)
    Download  
     
    Export citation  
     
    Bookmark   35 citations  
  • Relevant Information and Informed Consent in Research: In Defense of the Subjective Standard of Disclosure.Vilius Dranseika, Jan Piasecki & Marcin Waligora - 2017 - Science and Engineering Ethics 23 (1):215-225.
    In this article, we seek to contribute to the debate on the requirement of disclosure in the context of informed consent for research. We defend the subjective standard of disclosure and describe ways to implement this standard in research practice. We claim that the researcher should make an effort to find out what kinds of information are likely to be relevant for those consenting to research. This invites researchers to take empirical survey information seriously, attempt to understand the cultural context, (...)
    Download  
     
    Export citation  
     
    Bookmark   10 citations  
  • Lethal Injection in Uncharted Territory: The Need to Ensure the Humanity of Current Death Penalty Practices.Rebecca Salk - 2015 - Criminal Justice Ethics 34 (3):284-311.
    When lethal injection was first legalized in the late 1970s, many people viewed it as safe, reliable, and humane. Today, however, lethal injection does not always perform as promised. Due to difficulties with sourcing lethal injection drugs, states are utilizing untested lethal injection protocols, with little knowledge or experience to guide them. This article argues that lethal injection reform requires regulation similar to that for human subject research, and that the practice of utilizing untested lethal injection methods comes very close (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Ethical challenges for the design and conduct of mega-biobanking from Great East Japan Earthquake victims.Kenji Matsui & Shimon Tashiro - 2014 - BMC Medical Ethics 15 (1):55.
    Amid continuing social unrest from the Great East Japan Earthquake and subsequent Fukushima nuclear accident of 2011, the Japanese government announced plans for a major biobanking project in the disaster-stricken areas, to be administered by the ‘Tohoku Medical Megabank Organization’ (ToMMo). This project differs from previous biobanking projects in that it 1) was initiated mainly to boost post-disaster recovery and reconstruction; and 2) targets the area’s survivors as its primary subjects. Here, we review the ethics of the ToMMo biobanking project (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Ethical Considerations in Clinical Trials: A Critique of the ICH-GCP Guideline.Sharon Kaur & Choong Yeow Choy - 2012 - Developing World Bioethics 12 (3):20-28.
    This article examines issues relating to ethics decision-making in clinical trials. The overriding concern is to ensure that the well being and the interests of human subjects are adequately safeguarded. In this respect, this article will embark on a critical analysis of the ICH-GCP Guideline. The purpose of such an undertaking is to highlight areas of concern and the shortcomings of the existing ICH-GCP Guideline. Particular emphasis is made on how ethics committees perform their duties and responsibilities in line with (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Ethical Considerations for Volunteer Recruitment of Visual Prosthesis Trials.Yu Xia & Qiushi Ren - 2013 - Science and Engineering Ethics 19 (3):1099-1106.
    With the development of visual prostheses research from the engineering phase to clinical trials, volunteer recruitment for the early visual prosthesis trials needs to be carefully considered. In this article, we mainly discuss several issues related to volunteer recruitment that had posed serious challenges to the visual prosthesis trials, such as low rates of participants, high expectations and underlying motivations to participate in the visual prosthesis trials as well as the importance of informed consent. When recruiting volunteers for visual prosthesis (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation